- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 180M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 33.44M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $15K |
| Capex | Q1 2026 · Mar 31, 2025 | $51K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.5M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.15M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.64M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $18.62M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $10.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $28.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $33.01M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.86M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.67M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $16.34M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.11M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $47.09M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $53.32M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $51.88M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $58.62M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.22 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.22 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.89M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.62M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $5.16M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $6.57M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.03M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.26M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.34M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$12.01M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.71M |
| Revenue | Q1 2026 · Mar 31, 2025 | $172K |